Causality: autoimmunity and cancer
Keywords:
autoimmunity; cancer; inflammation; autoimmune diseases.Abstract
Introduction: The effectors of autoimmune diseases are the mechanisms of hypersensitivity. These processes also appear in cancer, which can give rise to autoinflammation.
Objective: To describe the causality between autoimmune diseases and cancer.
Methods: A literature review was performed using the Google Scholar and articles freely available on the basis of PubMed and Scielo January 2014 to February 2018. Data search terms were used as descriptors of the DeCS and MeSH.
Development: Autoimmune diseases are chronic inflammatory processes caused by failures in tolerance. The mechanisms and specific processes that initiate the damage are still unknown. The activity of inflammatory cells and soluble pro-inflammatory mediators leads to a greater recruitment of endothelial cells and promotes angiogenesis. Persistent inflammation (chronic or low grade) can often promote tumor development, tumor progression and invasion. In the tumor environment there is release of molecular patterns associated with damage (DAMPs), which mimic a sterile lesion and recruit cells of innate immunity, which can promote an inflammatory environment and cause an autoimmune phenomenon.
Conclusions: Inflammatory responses can improve tumor growth and progression. Cancer can develop self-immunity or arise secondary to the genetic and epigenetic changes of autoinflammation. The causality between cancer and autoimmunity is bidirectional, they perpetuate themselves and are the product of inflammatory processes.
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish in this journal agree to the following terms: Authors retain copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Creative Commons Attribution-NonCommercial License (CC BY-NC 4.0), which allows others to share the work provided that its authorship and initial publication in this journal are acknowledged. Authors may enter into separate, additional agreements for the non-exclusive distribution of the published version of the work (e.g., posting it to an institutional repository or publishing it in a book), provided that its initial publication in this journal is acknowledged. Authors are permitted and encouraged to share their work online (e.g., in institutional repositories or on their personal website) before and during the submission process, as this can lead to productive exchanges and increase citation of the published work (see The Effect of Open Access).
As the Revista Cubana de Investigaciones Biomédicas is part of the SciELO network, once articles have been accepted into the editorial process (peer review), authors may, if they agree, deposit them in SciELO Preprints and update them there once the review process and layout proofs are complete.
